ERBB2 and breast carcinoma: In contrast to breast cancer, there is evidence that in CRC; cytoplasmic HER2 could be associated with survival prognosis; as it may be involved in tumor pathogenesis like membranous HER2 in breast cancer (Blok et al., 2013).